InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Groenewald Ferdinand, Directeur Comptable. Director active across 4 companies, notably Muscle Maker, Inc.. Cumulatively, 5 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €10k. History available since 15 February 2022. The latest transaction was disclosed on 18 November 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Groenewald Ferdinand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
60,000 股0Common StockSEC:0001493152-25-024659:0
10,775 股0Common StockSEC:0000950170-25-110531:0
175,000 股0Common StockSEC:0001641172-25-013287:0
35,000 股0Common StockSEC:0001641172-25-006566:0
19,285 股@ US$0.58100.0% 占其流量Common StockSEC:0001493152-22-004963:0
5 条申报中的 5 条
About Groenewald Ferdinand
Groenewald Ferdinand is Directeur Comptable and has reported 5 filings in total. Across the 5 recent filings available, the reported sell amount is EUR 9893, with filings dated from 2022-02-18 to 2025-11-21. The companies mentioned in these filings are Muscle Maker, Inc., Streamex Corp., Alaunos Therapeutics, Inc. and BioSig Technologies, Inc., and the modal transaction nature is Attribution.
